# SSH3

## Overview
SSH3 is a gene that encodes the slingshot protein phosphatase 3, a member of the slingshot family of phosphatases. This family is primarily involved in the regulation of actin filament dynamics through the dephosphorylation of cofilin, an actin-binding protein. The SSH3 protein is characterized by a phosphatase domain similar to those found in dual-specificity phosphatases and protein tyrosine phosphatases, and it features a unique C-terminal region that acts as an autoinhibitory domain (Mizuno2013Signaling; Kousaka2008Slingshot‐3). Unlike its homologs SSH1 and SSH2, SSH3 does not bind to F-actin and is diffusely distributed in the cytoplasm and nucleus, which suggests a distinct regulatory mechanism (Ohta2003Differential). Although SSH3 is not essential for normal development in mice, it is highly expressed in epithelial cells and has been implicated in the progression of pancreatic cancer, where it influences cell proliferation and migration through the NOTCH1 signaling pathway (Kousaka2008Slingshot‐3; Yang2024SSH3).

## Structure
The SSH3 protein, a member of the slingshot family of phosphatases, is involved in the regulation of actin filament dynamics. Its molecular structure includes a phosphatase domain that shares similarities with dual-specificity phosphatases and protein tyrosine phosphatases (Mizuno2013Signaling). SSH3 is characterized by a unique C-terminal region, which acts as an autoinhibitory domain, reducing its phosphatase activity. Deletion of this C-terminal region results in increased activity, indicating its regulatory role (Kousaka2008Slingshot‐3).

SSH3 differs from its homologs SSH1 and SSH2 in several structural aspects. It has a Trp residue instead of a conserved Tyr, and an Arg instead of Lys, leading to a more congested active site and a higher KM value for its substrate (Lee2017Identification). Unlike SSH1 and SSH2, SSH3 does not bind to F-actin and is diffusely distributed in the cytoplasm and nucleus (Ohta2003Differential). This lack of F-actin binding is attributed to differences in its C-terminal region, which is not involved in F-actin binding as in SSH1 and SSH2 (Ohta2003Differential). The protein may also exist in different splice variant isoforms, which could affect its function and activity.

## Function
Slingshot protein phosphatase 3 (SSH3) is a member of the slingshot family of phosphatases, which play a crucial role in actin filament dynamics by dephosphorylating cofilin, an actin-binding protein. This dephosphorylation process is essential for actin filament turnover and reorganization, impacting cellular processes such as migration and morphogenesis (Mizuno2013Signaling; Lee2017Identification). SSH3 is less effective in dephosphorylating phospho-cofilin compared to other family members like SSH1 and SSH2, and it does not bind to F-actin, resulting in a diffuse distribution in the cytoplasm and nucleus (Mizuno2013Signaling; Huang2006Cofilin).

Despite its biochemical role, SSH3 is not essential for the development of certain epithelial tissues in mice, as evidenced by the lack of structural abnormalities in ssh-3 knockout mice (Kousaka2008Slingshot‐3). This suggests potential redundancy or compensation by other phosphatases in vivo (Kousaka2008Slingshot‐3). SSH3 is highly expressed in epithelial cells and is associated with epithelial differentiation, indicating a potential role in this process, although its exact cellular functions remain less understood compared to other SSH family members (Kousaka2008Slingshot‐3).

## Clinical Significance
The SSH3 gene has been implicated in the progression of pancreatic cancer (PC). It is significantly overexpressed in pancreatic cancer tissues compared to normal tissues, and this overexpression is associated with poorer overall survival and disease-free survival in patients. SSH3 promotes the proliferation and migration of pancreatic cancer cells by activating the NOTCH1 signaling pathway. Knockdown of SSH3 in PC cell lines results in decreased cell proliferation, migration, and invasion, indicating its role in cancer progression. The study also demonstrated that the NOTCH pathway agonist Jagged-1 could reverse the effects of SSH3 knockdown, suggesting a regulatory loop between SSH3 and the NOTCH pathway (Yang2024SSH3).

In contrast, studies in mice have shown that the SSH3 gene is dispensable for normal development, as SSH3 knockout mice do not exhibit any apparent structural abnormalities or developmental defects. This suggests that while SSH3 is not essential for normal development, its dysregulation may contribute to pathological conditions such as cancer (Kousaka2008Slingshot‐3). The potential of SSH3 as a therapeutic target is highlighted by its involvement in cancer cell dynamics and its association with poor prognosis in pancreatic cancer patients (Yang2024SSH3).

## Interactions
SSH3 (slingshot protein phosphatase 3) is part of the slingshot family of phosphatases, which are involved in the regulation of actin dynamics through the dephosphorylation of cofilin. Unlike its family members SSH1 and SSH2, SSH3 does not bind to F-actin and is distributed diffusely in the cytoplasm and nucleus (Mizuno2013Signaling). This lack of F-actin binding suggests a distinct regulatory mechanism for SSH3 compared to SSH1 and SSH2, which are activated by F-actin binding (Yang2018Allosteric).

SSH3 is less effective in dephosphorylating P-cofilin compared to SSH1 and SSH2, and its C-terminal tail may act as an autoinhibitory domain, as a C-terminally deleted mutant of SSH3 exhibits higher cofilin-phosphatase activity (Mizuno2013Signaling). Despite its role in dephosphorylating cofilin, SSH3 is dispensable for mouse development, as the loss of the ssh-3 gene does not result in significant developmental or viability issues in mice (Kousaka2008Slingshot‐3). The specific interactions of SSH3 with other proteins or nucleic acids are not detailed in the provided context, indicating a need for further research to elucidate its interaction network.


## References


[1. (Ohta2003Differential) Yusaku Ohta, Kazuyoshi Kousaka, Kyoko Nagata‐Ohashi, Kazumasa Ohashi, Aya Muramoto, Yasuyuki Shima, Ryusuke Niwa, Tadashi Uemura, and Kensaku Mizuno. Differential activities, subcellular distribution and tissue expression patterns of three members of slingshot family phosphatases that dephosphorylate cofilin. Genes to Cells, 8(10):811–824, October 2003. URL: http://dx.doi.org/10.1046/j.1365-2443.2003.00678.x, doi:10.1046/j.1365-2443.2003.00678.x. This article has 101 citations and is from a peer-reviewed journal.](https://doi.org/10.1046/j.1365-2443.2003.00678.x)

[2. (Kousaka2008Slingshot‐3) Kazuyoshi Kousaka, Hiroshi Kiyonari, Naoko Oshima, Akira Nagafuchi, Yasuyuki Shima, Osamu Chisaka, and Tadashi Uemura. Slingshot‐3 dephosphorylates adf/cofilin but is dispensable for mouse development. genesis, 46(5):246–255, April 2008. URL: http://dx.doi.org/10.1002/dvg.20389, doi:10.1002/dvg.20389. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/dvg.20389)

[3. (Yang2024SSH3) Chengxiao Yang. Ssh3 promotes pancreatic cancer proliferation and migration by activating the notch signaling pathway. American Journal of Cancer Research, 14(4):1815–1830, 2024. URL: http://dx.doi.org/10.62347/dazv7194, doi:10.62347/dazv7194. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.62347/dazv7194)

[4. (Yang2018Allosteric) Duxiao Yang, Peng Xiao, Qing Li, Xiaolei Fu, Chang Pan, Di Lu, Shishuai Wen, Wanying Xia, Dongfang He, Hui Li, Hao Fang, Yuemao Shen, Zhigang Xu, Amy Lin, Chuan Wang, Xiao Yu, Jiawei Wu, and Jinpeng Sun. Allosteric modulation of the catalytic vyd loop in slingshot by its n-terminal domain underlies both slingshot auto-inhibition and activation. Journal of Biological Chemistry, 293(42):16226–16241, October 2018. URL: http://dx.doi.org/10.1074/jbc.ra118.004175, doi:10.1074/jbc.ra118.004175. This article has 3 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra118.004175)

[5. (Mizuno2013Signaling) Kensaku Mizuno. Signaling mechanisms and functional roles of cofilin phosphorylation and dephosphorylation. Cellular Signalling, 25(2):457–469, February 2013. URL: http://dx.doi.org/10.1016/j.cellsig.2012.11.001, doi:10.1016/j.cellsig.2012.11.001. This article has 303 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2012.11.001)

[6. (Lee2017Identification) Seon Young Lee, Wooil Kim, Young Geun Lee, Hyo Jin Kang, Sang-Hyun Lee, Sun Young Park, Jeong-Ki Min, Sang-Rae Lee, and Sang J. Chung. Identification of sennoside a as a novel inhibitor of the slingshot (ssh) family proteins related to cancer metastasis. Pharmacological Research, 119:422–430, May 2017. URL: http://dx.doi.org/10.1016/j.phrs.2017.03.003, doi:10.1016/j.phrs.2017.03.003. This article has 44 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.phrs.2017.03.003)

[7. (Huang2006Cofilin) Timothy Y Huang, Céline DerMardirossian, and Gary M Bokoch. Cofilin phosphatases and regulation of actin dynamics. Current Opinion in Cell Biology, 18(1):26–31, February 2006. URL: http://dx.doi.org/10.1016/j.ceb.2005.11.005, doi:10.1016/j.ceb.2005.11.005. This article has 440 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ceb.2005.11.005)